Cargando…
Combination Treatment of Tamoxifen with Risperidone in Breast Cancer
Tamoxifen has long been used and still is the most commonly used endocrine therapy for treatment of both early and advanced estrogen receptor-positive breast cancer in pre- and post-menopause women. Tamoxifen exerts its cytotoxic effect primarily through cytostasis which is associated with the accum...
Autores principales: | Yeh, Wei-Lan, Lin, Hui-Yi, Wu, Hung-Ming, Chen, Dar-Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041865/ https://www.ncbi.nlm.nih.gov/pubmed/24886861 http://dx.doi.org/10.1371/journal.pone.0098805 |
Ejemplares similares
-
TARBP2-Enhanced Resistance during Tamoxifen Treatment in Breast Cancer
por: Wang, Ming-Yang, et al.
Publicado: (2019) -
Stratification of Tamoxifen Synergistic Combinations for the Treatment of ER+ Breast Cancer
por: Zboril, Emily K., et al.
Publicado: (2023) -
Mesenchymal Stem Cell-Induced Doxorubicin Resistance in Triple Negative Breast Cancer
por: Chen, Dar-Ren, et al.
Publicado: (2014) -
Inhibition of breast cancer with transdermal tamoxifen-encapsulated lipoplex
por: Lin, Yu-Ling, et al.
Publicado: (2016) -
Effects of Combined Pentadecanoic Acid and Tamoxifen Treatment on Tamoxifen Resistance in MCF−7/SC Breast Cancer Cells
por: To, Ngoc Bao, et al.
Publicado: (2022)